Search
Close this search box.
Register
Healthed-White-on-Blue
Search
Close this search box.

Infectious diseases

shutterstock_1711120204
Prof Nancy Baxter
Podcasts iconPodcasts

COVID update – Eris, pirola and other developments

New variants (Eris, Pirola) and ATAGI guidelines

Expert/s: Prof Nancy Baxter
patrick-assale-UH2x_pfV4MA-unsplash
Prof Catherine Bennett
Clinical Articles iconClinical Articles

The WHO has declared Eris a ‘variant of interest’. How is it different from other Omicron variants?

The World Health Organization (WHO) classified it as a “variant under monitoring” on July 19 after a surge in COVID

Expert/s: Prof Catherine Bennett, A/Prof Stuart Turville
xray-head
Nathan Cheetham
Clinical Articles iconClinical Articles

Long COVID: brain function still affected for some up to two years after infection – new research

Difficulties with cognitive functions or skills, such as the ability to recall memories, concentrate on tasks, or find the right words in conversation, are commonly reported following a COVID infection.

Expert/s: Nathan Cheetham
Image_Paul-Van-Buynder0
Prof Paul Van Buynder
Videos iconVideos

New pneumococcal 15-valent conjugate vaccine that includes coverage against serotype 3

In this Product Explainer, Public Health Physician and Infectious Diseases Epidemiologist Prof Paul Van Buynder explains the burden of pneumococcal disease in both children and adult population. He explains why PCV 15 has increased serotype coverage and why improved immunogenicity against serotype 3 is important both from a clinical and public health perspective (5 mins).

Expert/s: Prof Paul Van Buynder
pexels-george-milton-6953876
Prof Adrian Esterman
Podcasts iconPodcasts

COVID-19 – The latest information

Molnupiravir is still effective and protecting your most vulnerable patients

Expert/s: Prof Adrian Esterman
pexels-karolina-grabowska-4210606
Prof Frances Williams
Clinical Articles iconClinical Articles

Common diabetes drug metformin could protect against long COVID

here are no drugs to treat long COVID – a condition that affects around 2 million people in the UK alone

Expert/s: Prof Frances Williams
Paul-Griffin
Prof Paul Griffin
Videos iconVideos

Protein based COVID-19 vaccine

In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains the recombinant protein nanoparticle COVID-19 vaccine with a proprietary adjuvant, including the mechanism of action, efficacy, and tolerability; and provides an update on boosters, indications, and access (8 mins).

Expert/s: Prof Paul Griffin
Covid-19,Vaccine,,Doctor,Man,Pull,Syringe,On,Liquid,Bottle,Covid-19
Dr Gary Grohmann
Podcasts iconPodcasts

COVID update – Boosters, side effects, new waves

Vaccine-related injury, long COVID, more on boosters.

Expert/s: Dr Gary Grohmann
AProf John Litt
A/Prof John Litt AM
Videos iconVideos

Influenza vaccines for older adults in the 2023 influenza season

In this Product Explainer, Public Health Physician A/Prof John Litt AM explains the currently funded adjuvanted quadrivalent influenza vaccine for people 65 years and over and how it fits in the 2023 influenza season (6 mins). This product explainer is supported by Seqirus

Expert/s: A/Prof John Litt AM
Lung,Cancer,Or,Pneumonia.,Doctor,Check,Up,X-ray,Image,Have
Prof Adrian Esterman
Podcasts iconPodcasts

COVID Update – It’s not over yet

The current COVID situation- protect your vulnerable patients.

Expert/s: Prof Adrian Esterman
MicrosoftTeams-image-15
Dr Stuart Cooper
Clinical Articles iconClinical Articles

When it comes to vaccinations – don’t forget the old

Don’t forget routine immunisations and use any patient contact as an opportunity for vaccination—says Professor Nick Wood of the National Centre for Immunisation Research & Surveillance at the University of Sydney.

Expert/s: Dr Stuart Cooper
Cytomegalovirus,Cmv,,A,Dna,Virus,From,Herpesviridae,Family,,3d,Illustration.
Healthed
Clinical Articles iconClinical Articles

Cytomegalovirus lies dormant in most US adults and is the leading infectious cause of birth defects, but few have heard of it

“Why didn’t anyone tell me about this virus?” is a frequent response I hear from parents upon learning their newborn is infected with cytomegalovirus, or CMV. Although more than half of the U.S. population will be infected with CMV by the age of 40 and the disease is common worldwide, few people have ever heard of it.

Expert/s: Healthed

Education by clinicians, for clinicians

Get the app

Site

Company

Connect

Legal

Discover

Healthed

CPD platform